NCT05217745 (PASS) is a NA clinical trial of MLCT Oil in Non-Alcoholic Fatty Liver Disease, sponsored by National University Hospital, Singapore.

Who is sponsoring NCT05217745?

NCT05217745 is sponsored by National University Hospital, Singapore.

What drugs are being tested in NCT05217745?

Interventions in NCT05217745: MLCT Oil, LCT Oil (Corn Oil).

What condition does NCT05217745 study?

NCT05217745 studies Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, NAFLD.

Is NCT05217745 still recruiting?

NCT05217745 is currently status unknown. Last updated 25 February 2022.

Last reviewed 2022-02-25 · How we verify

NCT05217745: PASS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MLCT Oil for Fatty Liver - PASS Trial

Status unknown NA Last updated 25 February 2022

What this trial tests

NA trial testing MLCT Oil in Non-Alcoholic Fatty Liver Disease in 30 participants. Status unknown.

Timeline

5 August 2021

Primary endpoint
31 March 2022

31 March 2023

Quick facts

Lead sponsor	National University Hospital, Singapore
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	30
Start date	5 August 2021
Primary completion	31 March 2022
Estimated completion	31 March 2023
Sites	1 location across Singapore

Drugs / interventions tested

MLCT Oil
LCT Oil (Corn Oil)

Conditions studied

Non-Alcoholic Fatty Liver Disease — all drugs for Non-Alcoholic Fatty Liver Disease →
Non-Alcoholic Steatohepatitis — all drugs for Non-Alcoholic Steatohepatitis →
NAFLD — all drugs for NAFLD →

Sponsor

National University Hospital, Singapore

Who can join

Adults 21 to 65, any sex, with Non-Alcoholic Fatty Liver Disease or Non-Alcoholic Steatohepatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this randomised pilot study is to explore the relative efficacy of dietary MLCT oil versus LCT oil (corn oil) in augmenting therapy of overweight and obese NAFLD patients with at least a 1-stage reversal between F1 and F4.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Targeting the Adipose Tissue-Liver-Gut Microbiota Crosstalk to Cure MASLD.
Gabbia D, De Martin S. · · 2023 · cited 10× · PMID 38132297 · DOI 10.3390/biology12121471

Verify or expand the search:

Other recruiting trials for Non-Alcoholic Fatty Liver Disease

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07294963 — Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease · NA · recruiting
NCT07130318 — Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise · NA · recruiting
NCT06355310 — Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease · Phase 2 · recruiting
NCT06863376 — Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients · Phase 2 · recruiting

Other National University Hospital, Singapore trials

Trials by the same sponsor.

NCT06027983 — Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors · Phase 1, PHASE2 · not yet recruiting
NCT07460505 — Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure · NA · not yet recruiting
NCT07319676 — Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas · Phase 1, PHASE2 · recruiting
NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
NCT07091175 — Dupilumab Therapy in Nephrotic Syndrome in Children · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05217745 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National University Hospital, Singapore
Last refreshed: 25 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05217745.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing